cefazolin has been researched along with Obesity, Morbid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, R; Eley, V; Hopkins, G; Jackson, D; Lipman, J; Parker, SL; Roberts, JA; Ryan, RL; Van Zundert, AAJ; Wallis, SC | 1 |
| Coates, M; Hussain, Z; Peterson, GM; Shield, A | 1 |
| Asehnoune, K; Atthar, V; Cinotti, R; Dailly, E; Deslandes, G; Dumont, R; Grégoire, M; Jolliet, P; Letessier, E; Ronchi, L; Roquilly, A; Woillard, JB | 1 |
| Dalla Costa, T; de Araújo, B; Fischer, MI; Heineck, I; Meinhardt, NG; Palma, EC; Stein, AT | 1 |
| Chin, SJ; Clarke, HD; Moore, GA; Spangehl, MJ; Young, SW; Zhang, M | 1 |
| Asehnoune, K; Atthar, V; Cinotti, R; Dailly, E; Dumont, R; Grégoire, M; Letessier, E; Planche, L; Ronchi, L; Roquilly, A | 1 |
| Brill, MJ; Deneer, VH; Hazebroek, EJ; Houwink, AP; Knibbe, CA; Mouton, JW; Schmidt, S; Van Dongen, EP; van Ramshorst, B | 1 |
| Mannino, CM; Pop-Vicas, A; Salhab, M; Schmidhofer, S | 1 |
| Ahmadzia, HK; Coleman, JS; Heine, RP; Joshi, D; Liao, C; Patel, EM; Witter, F | 1 |
| Barkan, A; Brathwaite, CE; Chen, X; Cherasard, P; Chu, G; Cunha, BA; Hall, K; Islam, S; Nicolau, DP; Wang, S | 1 |
| Cliby, WA; Diehl, CL; El-Nashar, SA; Famuyide, AO; Stanhope, CR; Swanson, CL; Thompson, RL | 1 |
| Chan, K; Edmiston, CE; Krepel, C; Pevzner, L; Swank, M; Wing, DA | 1 |
| Deneer, VH; Diepstraten, J; Knibbe, CA; Taks, M; van de Garde, EM; van Dongen, EP; van Kralingen, S; van Ramshorst, B; Vlaminckx, B; Wiezer, MJ | 1 |
| Barie, PS; Dakin, GF; Ho, VP; Nicolau, DP; Pomp, A; Rich, BS; Towe, CW | 1 |
| Christou, NV; Forse, RA; Karam, B; MacLean, LD | 1 |
1 review(s) available for cefazolin and Obesity, Morbid
| Article | Year |
|---|---|
Prophylactic Cefazolin Dosing in Obesity-a Systematic Review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Humans; Obesity; Obesity, Morbid; Surgical Wound Infection | 2022 |
7 trial(s) available for cefazolin and Obesity, Morbid
| Article | Year |
|---|---|
Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets?
Topics: Administration, Intravenous; Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Gastrectomy; Humans; Male; Middle Aged; Models, Theoretical; Monte Carlo Method; Obesity, Morbid; Prospective Studies; Surgical Wound Infection | 2018 |
The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Awards and Prizes; Body Mass Index; Body Weight; Cefazolin; Female; History, 21st Century; Humans; Male; Middle Aged; Obesity; Obesity, Morbid; Orthopedics; Osteoarthritis, Knee; Prospective Studies; Prosthesis-Related Infections; Subcutaneous Fat; Vancomycin | 2018 |
Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bariatric Surgery; Calibration; Cefazolin; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Humans; Intraoperative Care; Male; Middle Aged; Obesity, Morbid; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 2017 |
Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery.
Topics: Adiposity; Adult; Anthropometry; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Cesarean Section; Female; Follow-Up Studies; Humans; Obesity; Obesity, Morbid; Pregnancy; Preoperative Care; Risk Assessment; Surgical Wound Infection; Treatment Outcome; Young Adult | 2011 |
Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Bariatric Surgery; Cefazolin; Female; Humans; Injections, Intravenous; Male; Obesity, Morbid; Prospective Studies; Protein Binding | 2011 |
Cefazolin dosing for surgical prophylaxis in morbidly obese patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Dose-Response Relationship, Drug; Elective Surgical Procedures; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Obesity, Morbid; Surgical Wound Infection | 2012 |
Antibiotic prophylaxis for surgery in morbidly obese patients.
Topics: Adipose Tissue; Cefazolin; Gastroplasty; Humans; Injections, Intravenous; Obesity, Morbid; Reoperation; Surgical Wound Infection | 1989 |
7 other study(ies) available for cefazolin and Obesity, Morbid
| Article | Year |
|---|---|
Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.
Topics: Anti-Bacterial Agents; Bariatric Surgery; Cefazolin; Extracellular Fluid; Humans; Obesity, Morbid | 2022 |
Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.
Topics: Adult; Antibiotic Prophylaxis; Bariatric Surgery; Cefazolin; Dose-Response Relationship, Drug; Female; Humans; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Models, Biological; Obesity, Morbid; Subcutaneous Tissue; Surgical Wound Infection; Young Adult | 2018 |
Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bariatric Surgery; Body Mass Index; Cefazolin; Drug Administration Schedule; Female; Gastrectomy; Humans; Male; Middle Aged; Obesity, Morbid; Subcutaneous Fat; Surgical Wound Infection | 2018 |
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Cefazolin; Female; Humans; Male; Microdialysis; Middle Aged; Models, Statistical; Obesity, Morbid; Plasma; Prospective Studies; Subcutaneous Tissue | 2014 |
Psoas abscess in an immunocompetent host.
Topics: Anti-Bacterial Agents; Arthralgia; Biomarkers; Cefazolin; Female; Flank Pain; Hip Joint; Humans; Immunocompetence; Leukocytosis; Low Back Pain; Middle Aged; Obesity, Morbid; Psoas Abscess; Tomography, X-Ray Computed | 2014 |
Obstetric Surgical Site Infections: 2 Grams Compared With 3 Grams of Cefazolin in Morbidly Obese Women.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cesarean Section; Female; Humans; Obesity, Morbid; Pregnancy; Pregnancy Complications; Retrospective Studies; Surgical Wound Infection; Young Adult | 2015 |
Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Ciprofloxacin; Cohort Studies; Drainage; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Obesity, Morbid; Ofloxacin; Retrospective Studies; Subcutaneous Fat, Abdominal; Surgical Wound Infection | 2010 |